Renal Tumors Classification, Biology and Banking Study

AREN03B2

Protocol Description

The purpose of this Children's Oncology Group study is to collect tumor tissue samples for analysis, which will help researchers learn more about renal tumors, helping doctors to improve upon treatments and better prescribe them.

Eligibility Criteria

Eligible candidates include patients of all ages who have been diagnosed with a kidney tumor, a tumor outside the kidney called a malignant rhabdoid tumor or an extra-renal Wilms tumor.
Boys: All ages
Girls: All ages

Requirements

With permission, a portion of the blood, urine and tumor tissue samples collected as part of normal clinical care for the condition will be put into the study for analysis. Copies of results of each participant’s imaging studies (ultrasound, MRI, CT, etc.) will also be provided to the study’s central review center for assessment.
Visits: None beyond normal clinical care
Duration: Not applicable

Status: Open for Enrollment

Source(s) of Support

Children’s Oncology Group (Study AREN03B2)
National Cancer Institute
Third Party

Primary Investigator

A. Kim Ritchey, MD

Contact Information

To get started, please contact
A. Kim Ritchey, MD
412-692-5055